Delivery Order SPE2DB20D2104-SPE2DB24FQ74X
Award Date 10/15/23
Potential Completion Date 10/16/23
Potential Value $60
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $120,780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Clobetasol Propionate 0.05% topical spray. As part of DLA's pharmaceutical supply chain support to the Department of Defense, this order will provide 125ml bottles of the corticosteroid medication to military treatment facilities from Amerisourcebergen's distribution center in Conshohocken, Pennsylvania. The one-day period of performance from September 14th to 15th, 2023...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $40,260 to Amerisourcebergen Drug Corporation for the supply of 125ml bottles of 0.05% clobetasol propionate topical spray. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 29th to 30th, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency functions to support military readiness by procuring and providing...
- The Defense Logistics Agency awarded a $429.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Clobetasol 0.05% solution. As the prime contractor, Amerisourcebergen will supply 25ml bottles of the prescribed dermatological medication to meet DLA requirements. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility between September 1-5, 2023. The delivery order was issued under DLA's pharmaceuticals and medical/surgical supply...
- The Defense Logistics Agency awarded a delivery order valued at approximately $1,227 to Amerisourcebergen Drug Corporation for Clobetasol 0.05% solution. To be performed in Conshohocken, Pennsylvania over a one-day period concluding on August 23, 2023, this firm-fixed-price contract calls for Amerisourcebergen to provide 50ml bottles of the dermatological corticosteroid to the DLA. As a major buyer of pharmaceuticals and medical supplies for the U.S. military, the DLA utilizes contracts like...
- The Defense Logistics Agency awarded a $1,870.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Clobetasol 0.05% solution in 50ml bottles. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania. Performance is required between June 29-30, 2023. The delivery order was placed against an existing DLA pharmaceutical supply contract vehicle to support the Agency's medical...
- The Defense Logistics Agency awarded a $1,467 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Clobetasol 0.05% solution. The order is for 50ml bottles of the topical corticosteroid medication to be delivered to DLA's location in Conshohocken, Pennsylvania by September 6, 2023. Amerisourcebergen will perform as the prime contractor, with delivery taking place under the existing DLA Pharmaceutical Prime Vendor contract vehicle. No set aside designation or subcontractors...
- The Defense Logistics Agency awarded a $59,530 delivery order to Amerisourcebergen Drug Corporation for Clobetasol 0.05% solution in 25ml bottles. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order runs from August 31, 2023 through September 1, 2023 to supply the generic topical corticosteroid to the Department of Defense. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the contracted products to DLA distribution...
- The Defense Logistics Agency awarded a $167,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Clobetasol 0.05% solution in 25ml bottles. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical to a facility in Conshohocken, Pennsylvania by August 28, 2023 in support of the Department of Defense's medical supply needs. No subcontractors or set aside designations were indicated. This delivery order was issued against an existing DLA pharmaceutical...
- The Defense Logistics Agency awarded a $531,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Clobetasol 0.05% solution. The order is for 25ml bottles of the topical corticosteroid medication to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania no later than June 28, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and supports military services and combatant commands worldwide. This small order...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $16,260 to Amerisourcebergen Drug Corporation for Clobetasol Propionate 0.05% topical foam. As the prime contractor, Amerisourcebergen will deliver 50-gram tubes of the prescribed corticosteroid to an agency facility located in Conshohocken, Pennsylvania over a one-day period beginning on August 22, 2023. The contract was issued under an existing DLA vehicle and no set aside designation was...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FQ74XDelivery Order
Defense Logistics Agency awarded a firm fixed price delivery order contract valued at sixty dollars to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract calls for the delivery of 125ml bottles of Clobetasol Prop 0.05% spray to support DLA programs. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania with an expected completion date of October 16, 2023. No set-aside provisions were applied to this award to supply the generic topical corticosteroid to meet DLA requirements.
Generated 1/14/24, 9:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60 | 10/15/23 |